MICHAEL JOHN TOMSICEK Insider Trading
Get free email notifications about insider trading for MICHAEL JOHN TOMSICEK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL JOHN TOMSICEK. MICHAEL JOHN TOMSICEK is a Vice President, CFO in ABIOMED INC ($ABMD) and a SVP & Chief Financial Officer in CUBIST PHARMACEUTICALS INC ($CBST) and a Director in Milestone Pharmaceuticals Inc. ($MIST) and a Chief Financial Officer in CRISPR Therapeutics AG ($CRSP).
Address: 65 HAYDEN AVENUE LEXINGTON 02421 MA
Companies in which MICHAEL JOHN TOMSICEK is an Insider
ABIOMED INC
Trading Symbol: ABMDIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of MICHAEL JOHN TOMSICEK: Vice President, CFO
Holdings: 27,081 shares
Current Value: $2,977,285
Latest Transaction: Jul 18 2017
$ABMD Market Capitalization: $4.72B
$ABMD Previous Close: $109.94
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CRISPR Therapeutics AG
Trading Symbol: CRSPIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL JOHN TOMSICEK: Chief Financial Officer
Holdings: 3,243 shares
Current Value: $51,077
Latest Transaction: Mar 12 2021
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CUBIST PHARMACEUTICALS INC
Trading Symbol: CBSTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL JOHN TOMSICEK: SVP & Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jan 21 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Milestone Pharmaceuticals Inc.
Trading Symbol: MISTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL JOHN TOMSICEK: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL JOHN TOMSICEK
Sentiment: All, ABMD, CRSP, CBST, MIST
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 133.88 | 25,360 | 3,395,197 | 25,360 | |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Payment of Exercise | F | 124.15 | 1,352 | 167,851 | 1,891 | 3.2 K to 1.9 K (-41.69 %) |
Mar 12 2021 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Buy | M | 0.00 | 2,833 | 0 | 3,243 | 410 to 3.2 K (+690.98 %) |
Oct 06 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 86.75 | 11,666 | 1,012,026 | 11,666 | |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | M | 17.75 | 12,000 | 213,000 | 156,000 | |
Sep 03 2020 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Sell | S | 93.18 | 2,800 | 260,904 | 410 | 3.2 K to 410 (-87.23 %) |